Nabil Saba, MD
@DrNabilSaba
Followers
1K
Following
2K
Media
50
Statuses
485
Director of Head & Neck Oncology, Vice Chair at @WinshipAtEmory. Medical Oncologist; H&N cancer expert. Opinions=my own https://t.co/CXZsMJ6Sg2
Atlanta, GA
Joined October 2014
Excellent discussions and thoughtful debates by #HNCA experts at our 9th Updates in HNCA @WinshipAtEmory @EmoryUniversity symposium, @StokedStokes @NikkiSchmittMD @ConorSteuerMD @soumon_rudra @JamesBatesMD @markmcdonaldmd @RenataFerr92632 @ Dan Zandberg
0
0
0
RT @DrNabilSaba: Still time to register! Join our esteemmed faculty @EmoryUniversity @WinshipAtEmory Updates in #HNCA .
acrobat.adobe.com
View this file, and add comments too.
0
4
0
Blazing-fast image creation – using just your voice. Try Grok Imagine.
327
656
4K
RT @AUB_Lebanon: A Festschrift honoring Dr. Fadlo R. Khuri, president of the American University of Beirut (#AUB), brought together an extr….
0
9
0
RT @JAMAOto: In patients with SCCHN receiving radiation with C/P vs cisplatin, there were no differences in locoregional recurrence-free su….
0
7
0
Still time to register! Join our esteemmed faculty @EmoryUniversity @WinshipAtEmory Updates in #HNCA on September 6th; @StokedStokes @NikkiSchmittMD @ConorSteuerMD.
acrobat.adobe.com
View this file, and add comments too.
0
4
6
Join us in Atlanta on Sept 6th for Updates in the Management of Head and Neck Cancer Symposium featuring known experts @WinshipAtEmory @DanZandberg Renata Ferrarotto @NikkiSchmittMD @ConorSteuerMD @StokedStokes
1
1
2
0
1
0
RT @NikkiSchmittMD: Excited to share our study of RT + IAP antagonist tolinapant in cis-ineligible HNSCC, showing safety/feasibility and pr….
0
2
0
RT @eaonc: “The results support chemotherapy before surgery as an effective intervention to improve preservation of vital organs, bone, and….
0
3
0
Excellent presentation by @ConorSteuerMD covering reversal of immunosuppressive environment with #pepinemab in #HNCA @ASCO CSS @WinshipAtEmory @EmoryUniversity @LesinskiLab @Vaccinex @NikkiSchmittMD
0
2
18
RT @UPMCHillmanCC: Planning your day for @ASCO? Join @DanZandberg for an oral presentation on cSCC. #ASCO25 @UPMCPhysicianEd @UPMCnews http….
0
3
0
Great #ASCO25 discussion by @anantm around AI based prediction models in #HNCA @WinshipAtEmory @EmoryUniversity @ASCO @MedAIEmory
1
3
16
RT @eaonc: EA3231 is a phase 3 #ClinicalTrial of targeted therapy vs. chemotherapy in patients with differentiated #ThyroidCancer (DTC) wit….
0
1
0
RT @anantm: 🚨 New pub alert in Eur J of Cancer🚨.We introduce VISTA, an AI-virtual staining tool transforming H&E to IHC to detect M2-TAMs i….
0
4
0
RT @anantm: In @eBioMedicine we present SMuRF, a Swin Transformer-based model for fusing CT & HE slides to predict survival & tumor grade i….
0
2
0
INO-3107 DNA immunoRx induction of CD8+ HPV 6 & 11 T cell trafficking in #RRP another proof of principle in another #HPV related disease @InovioPharma @WinshipAtEmory @ucincinnati @JohnsHopkins. Source: Nature
nature.com
Nature Communications - In this phase 1/2 trial, the authors show that INO-3107, a DNA immunotherapy designed to elicit an immune response against HPV-6 and -11 recurrent respiratory...
0
0
1
RT @ASCO: We’ve issued new guidelines on the use of transoral robotic surgery in the treatment of oropharyngeal #SquamousCellCarcinoma: htt….
0
6
0
Sharing our recently published encouraging long term outcomes of Pembrolizumab and Cabozantinib in #RMHNSCC @WinshipAtEmory @MoffittNews
0
0
12
RT @WinshipAtEmory: 🎉Congrats to Winship researcher Canhua Xiao, PhD, RN, FAAN, on being awarded a $3.3M grant from @theNCI to study the ps….
0
1
0